Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group nucleosome binding domain 1 pseudogene designates one of several non-coding genomic loci that resemble the protein-coding gene High mobility group nucleosome binding domain 1 (HMGN1), but do not produce functional protein products. These pseudogenes are typically denoted in humans by names such as HMGN1P1, HMGN1P15, etc., and are catalogued by different identifiers depending on their chromosomal location[1][3]. They are artifacts of gene duplication or retrotransposition events and do not serve as drug targets, nor are they involved in canonical biological pathways relevant to disease or pharmacology. For functional and drug target information, see the protein-coding gene High mobility group nucleosome binding domain 1 (HMGN1), a chromatin-associated protein with established roles in gene regulation and immunity[2][7]. This, however, is a distinct entity from the pseudogene referenced by ENSG00000258500.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group nucleosome binding domain 1 pseudogene.